title: Current testing methods and challenges for detection of adventitious viruses.
abstract: CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA) Adventitious viruses are a major safety concern in biological products. This paper discusses various sources of virus contamination and approaches to develop a comprehensive detection and mitigation strategy for product safety. Additionally, general safety concerns related to adventitious agents in biologics and current testing recommendations by the Center for Biologics Evaluation and Research for demonstrating the absence of adventitious agents in viral vaccines will be presented. The limitations of the conventional assays and the need for and consideration of new technologies for broad detection of novel agents will also be discussed.
authors.affiliation: Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD, 20892, USA.
authors.forename: Arifa S
authors.initials: AS
authors.lastname: Khan
mesh_terms: D001688:Biological Products; D004340:Drug Contamination / Q000517:prevention & control; D006801:Humans; D057230:Limit of Detection; D012495:San Francisco; D014612:Vaccines; D014765:Viral Vaccines; D014780:Viruses
chemical_list: D001688:Biological Products; D014612:Vaccines; D014765:Viral Vaccines